Here’s what you should know:
1. The FDA’s Associate Commissioner For Strategic Initiatives Keagan Lenihan will lead the task force. It will include FDA, CMS and Department of Veterans Affairs representatives.
2. The group is charged with looking for “holistic solutions to addressing the underlying causes for the shortages,” according to a July 12 statement by FDA Commissioner Scott Gottlieb, MD.
3. The task force expands upon the work of a group created by the FDA Safety and Innovation Act of 2012.
4. The task force plans to engage the public and hold a meeting with stakeholders in the coming months.
More articles on supply chain:
Drugs & medical supplies costs at ASCs across the US — 7 statistics
ASC supply chain tip of the day: Take an outcomes-based approach
After presidential outcry, Pfizer delays raising drug prices — 6 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.